Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures FTSE (0.24%), DAX (0.31%), CAC40 +0.08%

Oct 28 ,2026

  • Synopsis

    • European equity markets are set for a mixed open with Asia equities mostly higher Wednesday. Very strong gains for the Kospi in the wake of SK Hynix's quarterly results; Taiwan's Taiex and the Nikkei 225 also higher. Greater China led higher by recovery in Shenzhen. Australia and Singapore near unchanged. India lower despite strong gains for Jio Platforms in its market debut. US futures mixed.

    • Bullish AI sentiment underpinned further by purchasing agreements, including Oracle collaboration agreements with Cerebras (inferencing), Google (TPUs), Nvidia (Vera Rubin to OCI), and OpenAI (enterprise computing).

    • In the UK, and following MPs questions on Scotland, there's weekly PMQs at 12noon GMT followed around 30 minutes later by Chancellor's budget/autumn forecast statement (UK parliament release, EY, Telegraph, IFS). At the conclusion of the speech, OBR's latest economic and fiscal outlook is released, with OBR Chair Jonathan Haskel presenting the reports key messages at 14:30 (livestream). Committee topics include work of National Energy System Operator (NESO) at 9:15, regulatory sandboxes in financial services and dunkelflaute and the risks of electricity intermittency, both at 10:00.

    • In central banks, the deadline for Eurogroup members to submit candidates to succeed ECB Executive board member Schnabel, who steps down 3-Jan. Chancellor Merz meeting with Japan's Takaichi and also plans to participate in the German-Japanese Business Summit.

    • Also taking place Wed are Economist's 4th annual Space Economy Summit (through Thu) whilst thyssenkrupp's (TKA.GR) materials division partial spin-off tk accelis (TKCC.GR) scheduled to start trading separately on the Frankfurt Stock Exchange (prospectus).

    • Macro data due include Germany Nov consumer confidence - GfK, Italy Sep PPI, Switzerland Oct economic sentiment index, Norway Sep retail sales, Ireland Sep retail sales.

    • A busy morning for earnings include from the Benelux region, ASM International (ASM.NA), Heineken (HEIA.NA), Royal KPN (KPN.NA) and Melexis (MELE.BB) updating investors whilst in the DACHs region, UBS (UBSG.SW), Deutsche Bank (DBK.GR), BASF (BAS.GR), Mercedes-Benz (MBG.GR), Sandoz (SDZ.SW), Straumann (STMN.SW) and Symrise (SY1.GR), with BASF raising its FY26 adjusted EBITDA guidance. In the Nordics, Equinor (EQNR.NO), Telenor (TEL.NO), Kone (KNEBV.FH) and Norwegian Air Shuttle (NAS.NO) released results, with Equinor raising its FY oil and gas production growth outlook. In France, BNP Paribas (BNP.FP), Saint-Gobain (SGO.FP), Danone (BN.FP) and Dassault Systemes (DSY.FP) reported results, with Dassault upgrading its FY guidance. In Southern Europe, Banco Santander (SAN.SM) and Ferrovial (FER.SM) updated investors, whilst in the UK, Standard Chartered (STAN.LN) reported Q3 earnings and guides FY operating income growth above previous guidance.

  • Politics/Macro/World News

    • John Healey to cut energy bills by scrapping green levies - The Times

    • Global 2027 inflation forecasts revised up, growth outlook improves

  • Top company news

    • Earnings/updates

      • Benelux

        • ASM.NA (ASM International) -- reports Q3 adj net income €315.4M vs consensus €313.1M; announces €300M buyback; guides Q4 and FY27

        • HEIA.NA (Heineken) -- reports Q3 revenue €8.09B vs FactSet €7.98B [5 est, €7.86-8.04B]; reiterates FY26 organic operating profit guidance

        • KPN.NA (Royal KPN) -- reports Q3 adj EBITDA AL €671M vs consensus €665.0M; on track to reach FY26 outlook

        • MELE.BB (Melexis) -- reports Q3 EPS €0.78 vs FactSet €0.84 [5 est, €0.75-0.91]

        • CRBN.NA (Corbion) -- reports Q3 operating income €39.3M vs year-ago €27.9M

        • ARCAD.NA (ARCADIS) -- reports Q3 operating EBITDA €148M vs FactSet €135.0M [1 est]

        • ONTEX.BB (Ontex Group) -- reports Q3 adjusted net income €0.4M vs year-ago €29.3M; lowers EBITDA guidance

        • ADYEN.NA (Adyen) -- Q3 revenue €738.1M vs FactSet €733.3M [15 est, €723.7-742M]

      • DACHs

        • UBSG.SW (UBS Group) -- reports Q3 EPS $0.85 vs consensus $0.85

        • DBK.GR (Deutsche Bank) -- reports Q3 net income €1.85B vs consensus €1.44B

        • BAS.GR (BASF SE) -- reports Q3 adj EPS €0.72 vs consensus €0.38; raises FY26 adj EBITDA guidance

        • MBG.GR (Mercedes-Benz Group) -- reports Q3 EPS €1.64 vs FactSet €1.26 [5 est, €1.12-1.36]

        • SDZ.SW (Sandoz Group) -- reports Q3 revenue $2.94B vs FactSet $3.01B [3 est, $2.96-3.04B]

        • STMN.SW (Straumann Holding) -- reports Q3 revenue CHF667.1M vs consensus CHF662.3M; organic growth +9.2% vs consensus +8.6%

        • SY1.GR (Symrise) -- reports Q3 revenue €1.31B vs consensus €1.28B; organic sales growth 5.3%; reaffirms FY26 outlook

        • TEMN.SW (Temenos) -- reports Q3 non-IFRS EPS $1.23 vs consensus $1.15; raises FY26 guidance for EBIT and EPS growth

        • DWS.GR (DWS Group) -- reports Q3 net income attributable €230M vs FactSet €266.4M [2 est, €257.9-275M]; reaffirms FY expectations

        • DHER.GR (Delivery Hero) -- Q3 trading update: revenue €4.35B vs FactSet €4.30B [1 est]; raises FY guidance across all four key metrics

        • DOKA.SW (dormakaba Holding) -- Q1 trading update: revenue CHF702.9M, +5.2% y/y; reiterates FY outlook

        • PAL.AV (Palfinger) -- reports 9M net income (€61.5M) vs year-ago €72.4M; expects FY revenue slightly above and EBIT slightly below previous year; adjusts 2030 revenue target to €2.8B

        • 2GCB.GR (Grupo Comercial Chedraui SAB de CV) -- reports Q3 EPS MXN1.66 vs year-ago MXN1.68

      • France

        • BNP.FP (BNP Paribas) -- reports Q3 net income €3.46B vs consensus €3.23B; confirms FY26 & FY28 targets and raises FY26 CET1 ratio target to >13%

        • SGO.FP (Compagnie de Saint-Gobain) -- reports Q3 revenue €11.62B vs StreetAccount €11.59B

        • BN.FP (Danone) -- reports Q3 revenue €7.23B vs consensus €7.18B

        • DSY.FP (Dassault Systemes) -- reports Q3 EPS €0.32 vs StreetAccount €0.31; guides Q4; upgrades FY guidance

        • RCO.FP (Remy Cointreau) -- reports Q2 sales €287.7M vs consensus €280.8M; confirms FY26-27 objectives

        • WLN.FP (Worldline) -- reports Q3 revenue €967.0M vs FactSet €957.0M [1 est]; confirms FY outlook

        • ATE.FP (Alten) -- reports Q3 revenue €1.06B vs FactSet €1.03B [1 est]

        • VRLA.FP (Verallia) -- reports Q3 adjusted EBITDA €171.9M, (5%) vs year-ago €180.5M

        • SCHP.FP (Seche Environnement) -- reports Q2 revenue €308.8M, +11% vs year-ago €277.3M; confirms FY outlook

        • CDA.FP (Compagnie des Alpes) -- reports Q4 revenue €277.7M, +2% vs year-ago €271.4M; raises outlook

        • PIG.FP (Haulotte Group) -- reports Q2 revenue €121M vs year-ago €121M

        • DEEZR.FP (Deezer) -- reports Q3 revenue €133.8M, +2% vs year-ago €131.4M

        • LIN.FP (Linedata Services) -- reports 9M revenue €121.4M vs year-ago €122.0M

      • Nordics

        • EQNR.NO (Equinor) -- reports Q3 EPS $1.20 ex-items vs consensus $1.37; raises FY oil & gas production growth

        • TEL.NO (Telenor) -- reports Q3 adjusted attributable net income NOK3.68B vs consensus NOK3.91B

        • KNEBV.FH (Kone) -- reports Q3 EPS €0.52 vs consensus €0.53; narrows FY revenue growth and adj. EBIT margin guidance

        • NAS.NO (Norwegian Air Shuttle) -- reports Q3 net income NOK1.84B vs FactSet NOK1.62B [6 est, NOK1.45-1.75B]

        • SSAB.A.SS (SSAB) -- reports Q3 EPS SEK1.56 vs consensus SEK1.64

        • AKSO.NO (Aker Solutions) -- reports Q3 EPS ex-items NOK1.45 vs FactSet NOK1.49 [8 est, NOK1.35-1.68]; guides FY revenue between NOK53-55B vs prior guidance NOK50-55B and FactSet NOK54.04B

        • BRG.NO (Borregaard) -- reports Q3 EPS NOK2.96 vs FactSet NOK2.15 [7 est, NOK2.00-2.26]

        • SANOMA.FH (Sanoma) -- reports Q3 adj. EPS €0.82 vs FactSet €0.91 [6 est, €0.89-0.93]; narrows FY26 earnings outlook to higher end

        • ALMB.DC (Alm. Brand) -- reports Q3 EPS DKK0.29 vs FactSet DKK0.29 [6 est, DKK0.26-0.30]

        • EPRO.B.SS (Electrolux Professional) -- reports Q3 EPS SEK0.74 vs FactSet SEK0.75 [4 est, SEK0.70-0.87]

        • BNOR.NO (BlueNord) -- reports Q3 adjusted EBITDA $221.2M vs FactSet $234.3M [3 est, $212.0-247M]

        • ACAST.SS (Acast) -- reports Q3 EPS SEK0.24 vs FactSet SEK0.23 [1 est]

        • FSECURE.FH (F-Secure) -- reports Q3 adj. EPS €0.03 vs FactSet €0.04 [6 est, €0.03-0.05]

        • LUOTEA.FH (Lassila & Tikanoja) -- reports Q3 EPS €0.09 vs FactSet €0.10 [2 est, €0.09-0.10]; confirms updated FY outlook

        • GLA1V.FH (Glaston) -- reports Q3 comparable EPS €0.04 vs FactSet €0.02 [1 est]; confirms FY outlook

        • NETEL.SS (Netel Holding) -- reports Q3 EPS from cont. ops. (SEK0.52) vs year-ago (SEK0.99)

      • Southern Europe

        • SAN.SM (Banco Santander) -- reports Q3 net income attributable €3.43B vs FactSet €3.48B [12 est, €2.92-3.85B]

        • FER.SM (Ferrovial) -- reports 9M adjusted EBITDA €1.21B, +17% vs year-ago €1.03B

        • VID.SM (Vidrala) -- reports 9M EPS €4.99 vs year-ago €4.69; reiterates FY26 targets

        • LDA.SM (Linea Directa Aseguradora) -- reports Q3 net income €28.3M vs FactSet €25.7M [5 est, €24.5-27M]

      • UK

        • STAN.LN (Standard Chartered) -- reports Q3 EPS $0.69 vs consensus $0.54

    • M&A

      • ESKOB.FH (Kesko) -- estimates completion date of Kesko's Dahl acquisition

      • 4613.JP (Kansai Paint) -- completes acquisition of 50% stake in Türkiye's Polisan Kansai Boya

      • VSVS.LN (Vesuvius) -- announces extension of PUSU deadline to 24-Nov for proposal from RHI Magnesita

      • ELCO.LN (Eleco) -- shareholders approve acquisition by Accel-KKR

      • AX1.AU (Accent Group) -- Frasers declares A$0.65/sh offer to acquire Accent Group is best and final and will not be increased

      • ALUNI.FP (UNIFY Group) -- [announces acquisition of Option Finance, a B2B media group dedicated to professionals in finance, business law, asset management, and insurance; price not disclosed

      • Anthropic provides update on drug development, life sciences team, and the acquisition of Mithril Medicine

    • Healthcare

      • GSK.LN (GSK Plc) -- Transcript Intelligence: GSK Plc at European Society for Medical Oncology Congress

      • ROP.SW (Roche Holding) -- announced the global launch of the VENTANA BAP1 test

      • IDIA.SW (Idorsia) -- initiates pivotal Phase 3 kidney biopsy study of lucerastat in adult patients with Fabry disease; enters co-development and commercialization agreement with Nxera Pharma Co., Ltd.

      • ATORX.SS (Alligator Bioscience) -- Alligator Bioscience's board proposes 1-for-1000 reverse share split

      • 1877.HK (Shanghai Junshi Biosciences) -- reports final analysis results from Phase 3 NEOTORCH study presented at ESMO

    • Other

      • EQNR.NO (Equinor) -- commence the fourth tranche of up to $1.125B of the share buy-back program for 2026

      • ISP.IM (Intesa Sanpaolo) -- meets capital requirement set by the ECB

      • KBC.BB (KBC Group) -- KBC's capital remains well above the minimum capital requirements

      • SPM.IM (Saipem) -- has been awarded two new offshore drilling contracts with a total value of ~$121M

      • BARN.SW (Barry Callebaut) -- launches Flavourcode, opening a new chapter in chocolate flavor innovation

      • Insurance Australia Group agrees to settlement of proceeding brought by White Oak

      • Magellan Aerospace signs Memorandum of Understanding with Saab to explore Gripen Manufacturing Opportunities in Canada

      • Oracle announces new and expanded partnerships at Investor Day meeting; Pure Plays extend gains in intraday themes (27-Oct)

      • WeRide forms insurance partnership program with Allianz, Ping An P&C; terms undisclosed

  • Key rating changes

    • Upgrades

      • GTT.FP (Gaztransport & Technigaz) -- to buy from neutral at Goldman Sachs

      • SOBI.SS (Swedish Orphan Biovitrum) -- to buy from hold at Pareto

    • Downgrades

      • RYA.ID (Ryanair Holdings) -- to underperform from neutral at Oddo

      • JMAT.LN (Johnson Matthey) -- to hold from buy at Berenberg

      • EMSN.SW (EMS-Chemie Holding) -- to neutral from buy at UBS

    • Initiations

      • SENS.SW (Sensirion Holding) -- neutral at Oddo

    • Other Actions

      • PST.IM (Poste Italiane) -- reinstated neutral at Goldman Sachs

  • Data

    • Nikkei +1.08% to 63954.19

    • Hang Seng +0.23% to 23093.98

    • Shanghai Composite +0.77% to 3676.47

    • S&P futures +1.8 vs prior close of 7758.3

    • €-$ (0.0010) or (0.09%) to 1.1117

    • $-¥ (0.04) or (0.03%) to 157.91

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.